Evaluation of Hypertension

The evaluation of patients with resistant hypertension should be directed toward confirming true treatment resistance; identification of causes contributing to treatment resistance, including secondary causes of hypertension; and documentation of target-organ damage. Accurate assessment of treatment adherence and use of good blood pressure measurement technique is required to exclude pseudo resistance. In most cases, treatment resistance is multifactorial in etiology with obesity, excessive dietary sodium intake, obstructive sleep apnea, and CKD being particularly common factors.

Target-organ damage such as retinopathy, CKD, and LVH supports a diagnosis of poorly controlled hypertension and in the case of CKD will influence treatment in terms of classes of agents selected as well as establishing a blood pressure goal of <130/80 mm Hg. Most patients who present with elevated blood pressure (BP) will have essential (idiopathic) hypertension; extensive laboratory evaluation for secondary causes in these patients is low-yield and cost-prohibitive. However, identification of a secondary cause may often lead to a cure of the elevated BP or to a decrease in the number and/or doses of antihypertensive agents and a reduction in the long-term cardiovascular risks of hypertension.

  • ELISA for AAAR and cardiac myosin
  • Laboratory tests for the investigation
  • Endocrine or hormonal regulation of BP
  • Diagnostic imaging modalities
  • Interventional cardiology
  • Teleradiology

Related Conference of Evaluation of Hypertension

November 02-03, 2017

3rd Global Summit on Heart Diseases

Bangkok, Thailand
November 16-17, 2017

Annual Conference on Hypertension & Cardiac Nursing

Atlanta, USA
December 04-05, 2017

International Heart Conference

Dallas, Texas, USA
December 11-12, 2017

22nd World Cardiology Conference

Rome, Italy
February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
19-20 March ,2018

Global Cardiology Congress 2018

Dubai,UAE
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
June 18-19, 2018

EuroSciCon Conference on Bacteriology

Paris, France
July 11-12, 2018

International Conference on Cardiovascular Imaging

Sydney,Australia
July 18-19, 2018

25th Annual Cardiology Conference

Atlanta, USA
September 10-12, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 17-19,2018

25th Annual Cardiologists Conference

Tin Shui Wai,Hong Kong
19-20 Sept ,2018

23rd World Cardiology Conference

Hong Kong
October 17-18, 2018

Global Cardiology Summit

Seoul, South Korea

Evaluation of Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in